{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:19:51Z","timestamp":1790615991445,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002669","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ctro.2023.100589","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:58:34Z","timestamp":1675047514000},"page":"100589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Brachytherapy boost in anal canal cancer \u2013 A GEC ESTRO PDR task force meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-4717","authenticated-orcid":false,"given":"Pierre","family":"Annede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-8083","authenticated-orcid":false,"given":"Christian","family":"Kirisits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-8836","authenticated-orcid":false,"given":"Bradley R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratislav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Westerveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctro.2023.100589_b0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100589_b0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5114\/jcb.2018.76884","article-title":"Brachytherapy boost after chemoradiation in anal cancer: a systematic review","volume":"10","author":"Frakulli","year":"2018","journal-title":"jcb"},{"key":"10.1016\/j.ctro.2023.100589_b0015","doi-asserted-by":"crossref","unstructured":"Balgobind BV, Koedooder K, Ordo\u00f1ez Z\u00fa\u00f1iga D, D\u00e1vila Fajardo R, Rasch CR, Pieters BR. A review of the clinical experience in pulsed dose rate brachytherapy. Br J Radiol. 2015;88(1055):20150310. 10.1259\/bjr.20150310. Epub 2015 Aug 20. PMID: 26290399; PMCID: PMC4743453.","DOI":"10.1259\/bjr.20150310"},{"issue":"4","key":"10.1016\/j.ctro.2023.100589_b0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0360-3016(97)00097-7","article-title":"Pulsed-dose-rate brachytherapy: Design of convenient (daytime-only) schedules","volume":"39","author":"Brenner","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2023.100589_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brachy.2016.02.006","article-title":"Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study","volume":"15","author":"Kumar","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2023.100589_b0030","doi-asserted-by":"crossref","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul 21;339:b2700.","DOI":"10.1136\/bmj.b2700"},{"key":"10.1016\/j.ctro.2023.100589_b0035","unstructured":"Rohatgi A. Webplotdigitizer: Version 4.5 [Internet]. 2021. Available from: https:\/\/automeris.io\/WebPlotDigitizer."},{"issue":"1","key":"10.1016\/j.ctro.2023.100589_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ctro.2023.100589_b0045","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC.; 2020. Available from: http:\/\/www.rstudio.com\/."},{"issue":"1","key":"10.1016\/j.ctro.2023.100589_b0050","first-page":"1","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"4","key":"10.1016\/j.ctro.2023.100589_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"6","key":"10.1016\/j.ctro.2023.100589_b0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5114\/jcb.2018.81025","article-title":"Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal","volume":"10","author":"Bertin","year":"2018","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.ctro.2023.100589_b0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2007.02.152","article-title":"Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma","volume":"6","author":"Oehler-J\u00e4nne","year":"2007","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.ctro.2023.100589_b0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0360-3016(00)01427-9","article-title":"Experience with split-course external beam irradiation +\/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal","volume":"49","author":"Kapp","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2023.100589_b0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00464-004-2287-z","article-title":"Multimodal therapy of anal cancer added by new endosonographic-guided brachytherapy","volume":"20","author":"Doniec","year":"2006","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.ctro.2023.100589_b0080","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.brachy.2019.08.005","article-title":"High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers","volume":"18","author":"Varela Cagetti","year":"2019","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.ctro.2023.100589_b0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.brachy.2016.08.003","article-title":"Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results","volume":"15","author":"Gryc","year":"2016","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ctro.2023.100589_b0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2006.03.013","article-title":"Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study","volume":"79","author":"Bruna","year":"2006","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100589_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5114\/jcb.2019.82804","article-title":"Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis","volume":"11","author":"Arcelli","year":"2019","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.ctro.2023.100589_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5114\/jcb.2021.106247","article-title":"Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients\u2019 health quality perception","volume":"13","author":"Bourdais","year":"2021","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.ctro.2023.100589_b0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.brachy.2018.12.009","article-title":"Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer","volume":"18","author":"Annede","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2023.100589_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2022.03.019","article-title":"High dose rate brachytherapy in the management of anal cancer: A review","volume":"171","author":"Ali","year":"2022","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100589_b0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2015.07.014","article-title":"A tumor control probability model for anal squamous cell carcinoma","volume":"116","author":"Muirhead","year":"2015","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100589_b0120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.radonc.2018.06.007","article-title":"Determinants for local tumour control probability after radiotherapy of anal cancer","volume":"128","author":"Johnsson","year":"2018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100589_b0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2023.100589_b0130","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ctro.2023.100589_b0135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.brachy.2013.05.007","article-title":"From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications","volume":"12","author":"Guinot","year":"2013","journal-title":"Brachytherapy"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:13:30Z","timestamp":1762503210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":27,"alternative-id":["S2405630823000149"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100589","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachytherapy boost in anal canal cancer \u2013 A GEC ESTRO PDR task force meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100589"}}